YWHAG-related epileptic encephalopathy (DEE56) is a rare genetic syndrome, affecting less than 50 known individuals, manifested by intellectual disability, epilepsy, and behavioral disorders. YWHAG encodes for the protein 14-3-3γ, involved in cell cycle regulation and signal transduction. 14-3-3 proteins are affected in neurodevelopmental disorders, such as Down Syndrome and Williams Syndrome, and neurodegenerative diseases, including Creutzfeldt-Jakob Disease and Parkinson’s Disease. Though sleep disorders have been described in up to 39% of individuals with DEE56, there is no literature on the characteristics or management of sleep in this population.
We present the case of a 10-year-old girl with intractable epilepsy and intellectual disability in the setting of DEE56, due to a heterozygous de novo YWHAG missense variant: c.169C>T p.(R57C). Her sleep disturbance began early in life, manifested by deficits in sleep initiation and maintenance, prolonged nighttime awakenings, and daytime somnolence. We discuss behavioral and pharmacologic sleep interventions utilized and present a medication regimen, which resulted in both improved sleep and seizure control.